📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A pilot study on use of live attenuated rotavirus vaccine (Rotarix™) as an infection challenge model. (2020)

First Author: Chilengi R

Attributed to: Human live-attenuated rotavirus to assess next-genchallenge with eration rotavirus vaccines in Africa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2020.09.023

PubMed Identifier: 33032844

Publication URI: http://europepmc.org/abstract/MED/33032844

Type: Journal Article/Review

Volume: 38

Parent Publication: Vaccine

Issue: 46

ISSN: 0264-410X